Positives

• In another report, a patient shared that Thymosin Alpha-1 was “the only thing” that helped them manage a recent relapse, highlighting its significant role in their recovery compared to other treatments Reddit.
  
  

Negatives

• Patients given thymosin alpha-1 in COVID cohorts have not seen restored CD4+ or CD8+ T lymphocyte counts compared with peers who didn’t take it, suggesting limited immune-restoration benefit Frontiers in Immunology.
• Patients trying experimental peptide protocols promoted online for chronic illness commonly report no measurable change despite months of injections, often discontinuing once the cost adds up CSN Cancer Survivors Network.

Hurdles & Side Effects

• Thymosin alpha-1 (Zadaxin/thymalfasin) is not FDA-approved for any condition in the U.S. and was placed in FDA Category 2 of restricted compounding peptides starting in 2023, leaving most patients to source through wellness clinics or offshore vendors NPR.
• Compounded thymosin alpha-1 typically runs $100-400 per month through licensed compounding pharmacies, and patients ordering from offshore research-chemical sites often report source-quality concerns, including suspect purity and inconsistent batch potency.